INDOCO REMEDIES LTD. - 532612 - Closure of Trading Window
TRADING WINDOW CLOSURE INTIMATION30-09-2022
30-09-2022
INDOCO REMEDIES LTD. - 532612 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Disclosure of Voting Results of the 75th Annual General Meeting of the Company held on Thursday, 22nd September, 2022 as required under Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Scrutinizers Report23-09-2022
INDOCO REMEDIES LTD. - 532612 - Link Of The Webcast Of 75Th AGM Of Indoco Remedies Limited Held On 22.09.2022
Link of the Webcast of 75th AGM of Indoco Remedies Limited held on 22.09.202223-09-2022
INDOCO REMEDIES LTD. - 532612 - Shareholders Approves Indoco Remedies Limited Employee Stock Option Plan - 2022
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations,2015, the members of the Company has approved Indoco Remedies Limited Employee Stock Option Plan - 2022 in its 75th Annual General Meeting held on 22nd September, 2022.23-09-2022
INDOCO REMEDIES LTD. - 532612 - Disclosure Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
1) Re-appointment of M/s Gokhale & Sathe, a Firm of Chartered Accountants, (Firm Registration No. 103264W) as Statutory Auditors of the Company for the second term of 5 consecutive years. 2.) Re-appointment of Ms. Aditi Panandikar (DIN: 00179113) as Managing Director 3). Re-appointment of Mr. Sundeep V Bambolkar (DIN: 00176613) as Jt. Managing Director23-09-2022
INDOCO REMEDIES LTD. - 532612 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 75th Annual General Meeting of Indoco Remedies Limited22-09-2022
Indoco Remedies' CRO clears USFDA inspection with no observation
The US Food and Drug Administration (USFDA) inspected AnaCipher from September 12-16, 2022, Indoco Remedies said in a regulatory filing.19-09-2022
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Indoco's AnaCipher CRO clears USFDA inspection with Zero 483s19-09-2022
Small cap pharma stock to turn ex-dividend tomorrow. Should you invest?
Indoco Remedies has announced a final dividend of 1.5 per equity share and a special dividend of 0.75 per equity share for the financial year FY22.13-09-2022
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement - Disclosure under Regulation 30 and Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations')27-08-2022